Photo: triloks/GettyImages
Dallas-based Verily, Alphabet's health data and AI subsidiary, launched Verily Me, a new consumer app aimed at closing gaps in care and allowing people to stay informed and involved in their healthcare.
According to the company, app users will be able to get customized recommendations from licensed clinicians who review their pertinent medical records from providers and health systems.
An AI companion app answers questions about the contents of a patient's health records, such as vaccination history or the name of a physician.
With the Verily Me app, users can also log their meals and get nutrition advice.
The app can also be used by members of Verily’s Lightpath individualized care program, funded by employers, payers and pharmacy benefit managers for the benefit of their employees or members, with multiple tiers of clinical support based on a member's needs.
"We created Verily Me to meet the consumer need for a simpler, more personalized healthcare solution,” Dr. Vindell Washington, chief clinical officer of Verily, said in a statement.
"Verily Me identifies care gaps and provides more personalized treatment recommendations, an important step towards our commitment to equipping individuals with the tools they need to better manage their health."
THE LARGER TREND
Earlier this month, Verily announced a multi-year collaboration with UCHealth, the University of Colorado Anschutz and RefinedScience to change how data is used and care is delivered.
UC Anschutz and UCHealth collected biomedical data on the Verily platform, creating AI-ready, research-grade biomedical data pipelines and developing novel AI/ML models across crucial therapeutic areas, including oncology, cardiovascular, musculoskeletal, neuroscience, ophthalmology and transplant medicine.
In June, Verily announced the extension of its partnership with Vanderbilt University Medical Center (VUMC) to support the National Institutes of Health (NIH) All of Us Research Program’s Researcher Workbench platform.
The extended collaboration was aimed at continuing Verily's work alongside VUMC and other partners to provide researchers with secure, cloud-based access to study biomedical data via the Researcher Workbench platform.
In May, Verily was awarded a $14.7 million research grant from the Michael J. Fox Foundation (MJFF) for Parkinson's research to generate a detailed molecular dataset of Parkinson's disease.
The initiative integrated advanced molecular profiling with an extensive body of clinical, imaging and wearable data collected via the Personalized Parkinson's Project (PPP).
The PPP is a two-year longitudinal study conducted in collaboration with Radboud University Medical Center that involved 520 people diagnosed with Parkinson's disease.
In 2024, a consortium that included Verily, DataTecnica, Technome, Sage Bionetworks, the Broad Institute of MIT and Harvard, Vanderbilt University Medical Center and Northwestern University Feinberg School of Medicine received a $4.8 million award from the National Institutes of Health for the first year of a potential three-year project focused on delivering a centralized portal and tools that will enable researchers to analyze data across existing accelerating medicines partnership platforms.
The initiative, called Systems Biology Data Platform (SysBio) Leveraging the Accelerating Medicines Partnership, or “SysBio,” was funded through NIH’s Common Fund Venture Program.
The partners provided SysBio FAIRplex, a FAIR PLatform for EXploration of Systems Biology, which integrated varied data types, including phenotypic, clinical, molecular and patient reported outcomes data collected through the various AMP programs.
